- European indices are changing direction again, amid expectations of a resolution to the conflict in Iran. Most of the major benchmarks on the Old Continent are posting moderate losses. Germany’s DAX (-0.7%) is leading the declines, while IBEX and AEX are performing relatively well, up around 0.1%.
- German inflation data have been released. Inflation as measured by the European HICP came in at 2.0% year-on-year and 0.4% month-on-month. CPI according to the Federal Statistical Office was 1.9% year-on-year and 0.2% month-on-month. Both readings were in line with market expectations.
- Germany’s Rheinmetall reported its 2025 results. Despite strong revenue growth (€9.9 billion, up 29%), a solid improvement in margins (up to 18.5%), and optimistic guidance (expected 2026 sales of €14 billion), it was not enough to meet market expectations. The company’s shares are down about 5% following the results.
- Porsche’s CEO indicates the company may face another round of job cuts. The company is also considering introducing new models in segments aimed at boosting profits.
- The International Energy Agency is increasingly seriously considering releasing part of its oil reserves. WSJ journalists report that decision-makers they reached note that the volume released could be larger than the 182 million barrels released in 2022.
- Oracle reported results that beat market expectations; the stock is up nearly 9% in pre-market trading. Revenue rose to $17.19 billion and EPS reached $1.79. The strongest revenue growth came from the cloud segment, up as much as 44%.
- Markets are awaiting U.S. consumer inflation (CPI) data. The consensus expects year-on-year inflation to remain at 2.4% and the monthly reading to rise from 0.2% to 0.3%.
BREAKING: Another big increase of oil inventories despite Middle East disruption
BREAKING: ISM shows that expansion continues but inflationary pressures surge
🔴US100 Caps Gains Following Trump's Comments
US Open 🗽US500 gains ahead of the opening session on Wall Street
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
